BERLIN (Reuters) -German pharma company Bayer reported positive study results for its anticoagulant asundexian on Sunday, two years after a research setback for the promising blood thinner candidate.
In a Phase III study, a daily dose of 50 milligrams significantly reduced the risk of ischemic stroke compared with a placebo, Bayer said.
Detailed results from the OCEANIC-STROKE study will be presented at an upcoming scientific congress, said Bayer.
Bayer added that it plans to speak with health authorities worldwide in preparation for the submission of marketing authorisation applications.
Bayer had originally predicted that asundexian would have peak sales potential of more than 5 billion euros ($5.76 billion) - more than any of its other drugs.
At the end of 2023, the company had a major setback with the drug after it failed in a pivotal clinical trial involving patients with atrial fibrillation and a risk of stroke.
($1 = 0.8687 euros)
(Reporting by Joern Poltz. Writing by Miranda Murray. Editing by Jane Merriman)
LATEST POSTS
- 1
Over 1,800 killed since junta seized power in Burkina Faso, rights group says - 2Step by step instructions to Contrast Lab Jewels and Regular Ones
- 3Going with Children: Tips for Tranquil Family Get-aways
- 4Africa's energy giants eye long-term gains on Iran war disruption
- 55 Eating routine Well disposed Snacks to Keep You Fulfilled
- Benedict Cumberbatch takes on something even Sherlock can’t solve: male grief
- Consumer outlook on UK economy falls to two-year low
- Reality TV star Spencer Pratt, who lost his home in Palisades Fire, is running for mayor of Los Angeles
- 'Set up an Army Radio station at President’s Residence': Source close to Katz slams Herzog
- Pfizer in $41.5 million settlement with Texas over ADHD drug for children
- Solar storms can trigger auroras on Earth. This star’s explosion could destroy a planet’s atmosphere
- Vote in favor of your Number one method for commending a birthday
- Ukrainian man arrested in Germany on suspicion of spying for Russia
- Most loved Well known Accessory Styles For 2024
